Cary, NC (PRWEB) May 13, 2013
TrialCard Incorporated (“TrialCard”) announces the issuance of U.S. Patent No. 8,407,095 for a “Method of Delivering a Pharmaceutical Product via a Medium.” TrialCard has patented the technology that allows brand managers to uniquely customize their program business rules for each patient. The invention leverages TrialCard’s co-pay card technology by blending program business rule intelligence and co-pay variable values in a medium to promote pharmaceutical products. This patent is an expansion of TrialCard’s Adjusting ValueTM technology (U.S. Patent No. 7,925,531) which optimizes promotional programs that offer “Pay No More Than…” or ‘Save Up To…” savings with a prescription co-pay card.
David Cunningham, CEO and founder of TrialCard, says, “This patent affirms our position that the Adjusting ValueTM technology is unique to TrialCard. This is a game changer!”
TrialCard holds a variety of patents for its customizable solutions. TrialCard continues to improve patient access to medicines, facilitate patient reimbursement, and provide measurable ROI to pharmaceutical brands. The issuance of U.S. Patent No. 8,407,095 is another example of the TrialCard Difference.
About TrialCard Incorporated –
TrialCard Incorporated provides a comprehensive portfolio of Post-Script Solutions™ at Point of Care, Patient Access Management, and Point of Sale for the life-cycle of pharmaceutical brands. Since opening its doors in 2001, TrialCard has been awarded eight patents related to the processing and marketing of patient access programs. TrialCard is the largest provider of patient access programs in the industry, processing over $1 billion in patient benefits per year to help brand manufactures achieve their goals with prescribers, patients and pharmacists. For more information on TrialCard, please visit http://www.trialcard.com.